Once ingested, lignans are converted by gut bacteria into biologically active compounds called enterolignans. These enterolignans can bind to estrogen receptors, mimicking the hormone's effects, though much weaker. This interaction is thought to play a role in modulating hormone-related cancers, such as breast and prostate cancer. Additionally, lignans have antioxidant and anti-inflammatory properties that may further contribute to their potential anti-cancer effects.
